Bio-Techne (TECH) Gross Margin (2009 - 2026)

Bio-Techne (TECH) posted quarterly Gross Margin of 66.88% for Q1 2026, down 97.0% year-over-year from 2229.48% in Q1 2025, and up 3.46% quarter-over-quarter from 64.65% in Q4 2025.

Bio-Techne (TECH) Gross Margin (2009 - 2026) Analysis & Trends

Bio-Techne's Gross Margin history runs 18 years deep, the most recent figure standing at 66.88% for Q1 2026.

  • In Q1 2026, Gross Margin fell 97.0% year-over-year to 66.88%; the TTM figure through Mar 2026 stood at 64.96% (down 80.0% YoY), while the FY2025 annual figure was 64.8%, down 161.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 66.88%, up from 64.65% in the prior quarter.
  • The five-year high for Gross Margin was 8979.75% in Q3 2022, with the low at 62.72% in Q2 2025.
  • The 5-year median for Gross Margin is 66.88% (2026), against an average of 590.86%.
  • The sharpest annual moves came in 2022 and 2023: Gross Margin soared 891340 bps in 2022, then sank 891288 bps in 2023.
  • Bio-Techne's Gross Margin stood at 67.52% in 2022, then declined by 4 bps to 64.78% in 2023, then rose by 1 bps to 65.27% in 2024, then declined by 1 bps to 64.65% in 2025, then gained by 3 bps to 66.88% in 2026.
  • Business Quant data shows TECH's Gross Margin at 66.88% in Q1 2026, 64.65% in Q4 2025, and 65.65% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 91.59%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 90.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 89.76%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 60,631,834.75%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 76.90%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 84.20%
10 Bio-Techne 11.33 Bn 11.12 Bn 208.29 Mn 66.88%

Historic Data

Download Data
DateValue
Mar 31, 2026 66.88%
Dec 31, 2025 64.65%
Sep 30, 2025 65.65%
Jun 30, 2025 62.72%
Mar 31, 2025 67.86%
Dec 31, 2024 65.27%
Sep 30, 2024 63.23%
Jun 30, 2024 66.43%
Mar 31, 2024 67.43%
Dec 31, 2023 64.78%
Sep 30, 2023 66.87%
Jun 30, 2023 67.93%
Mar 31, 2023 68.73%
Dec 31, 2022 67.52%
Sep 30, 2022 8,979.75%
Jun 30, 2022 69.51%
Mar 31, 2022 69.38%
Dec 31, 2021 68.22%
Sep 30, 2021 66.35%
Jun 30, 2021 67.92%